<p>RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to prov
<p>Breaking through the $2135 level will set up the main scenario of a 161.8% growth, which in this case is close to $2500.</p> <p>The post <a href="https://forextv.com/crypt
Leave a Comment